Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.3274
Delayed Data
As of Apr 29
 +0.0024 / +0.74%
Today’s Change
0.20
Today|||52-Week Range
0.44
-19.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues1.2M2.2M2.7M2.2M
 
 
 
 
 
Cost of Goods Sold903.7K1.2M1.4M835.7K
 
 
 
 
 
Depreciation And Amortization--161.5K164.3K166.8K
 
 
 
 
 
Operating ExpensesGross Income330.5K804.7K1.1M1.2M
 
 
 
 
 
General Expenses5.9M3.2M5.1M3.9M
 
 
 
 
 
Research And Development4.8M2.4M4.2M3.2M
 
 
 
 
 
Total Operating Expenses6.8M4.6M6.7M4.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.5M-2.4M-4.0M-2.7M
 
 
 
 
 
Extraordinary Credit--7.2M2.1M0.00
 
 
 
Extraordinary Charge-3.5M0.000.00-9.5M
 
 
 
Interest Expense On Debt72.8K72.7K63.8K68.1K
 
 
 
 
 
Other Expenses7.00-2.8K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.1M4.7M-1.9M-12.2M
 
 
 
 
 
Net Income-9.1M11.2M-7.0M-37.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS631.1M646.9M665.3M684.8M
 
 
 
 
 
Shares To Calculate EPS Diluted631.1M812.6M823.5M836.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.01$0.00$0.00-$0.05
 
 
 
EPS Diluted-$0.01$0.01-$0.01-$0.05